A pharmacogenomics study for adverse effects and clinical outcome to S-1 in gastric cancer patients
Not Applicable
Recruiting
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000004968
- Lead Sponsor
- Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Known prior severe hypersensitivity to clinical trial medicines 2) Patients who do not have enough whole body state to the antineoplastic agents treatment 3) Pregnant, breastfeeding or expecting woman 4) Other clinical difficulties in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method